Reduced immobility in the forced swim test in mice with a targeted deletion of the leukemia inhibitory factor (LIF) gene

Neuropsychopharmacology

Volumn 29, Issue 4, 2004, Pages 770-776

  Pechnick, Robert N ^a   Chesnokova, Vera M ^a   Kariagina, Anastasia ^a   Price, Shannon ^a   Bresee, Catherine J ^a   Poland, Russell E ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal models; Cytokine; Gene deletion; Inflammation; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DEPRESSION; FEMALE; FORCED SWIMMING TEST; GENE; GENE DELETION; IMMOBILIZATION; INFECTION; INFLAMMATION; KNOCKOUT MOUSE; LEUKEMIA INHIBITORY FACTOR GENE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; GENE DELETION; IMMOBILIZATION; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEX FACTORS; SWIMMING;

EID: 1642529474     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300402     Document Type: Article

References (51)

1. Akita S, Readhead C, Stefaneanu L, Fine J, Tenpanaru-Sermesilu A, Kovacs K, et al. (1997). Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function. J Clin Invest 99: 2462-2469.
2. Auernhammer C, Chesnokova V, Melmed S (1998). Leukemia inhibitory factor modulates interleukin-1β-induced activation of the hypothalamo-pituitary- adrenal axis. Endocrinology 139: 2201-2208.
3. Auernhammer CJ, Melmed S (2000). Leukemia-inhibitory factor - neuroimmune modulator of endocrine function. Endocrine Rev 21: 313-345.
4. Barkhudaryan N, Dunn AJ (1999). Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis. Neurochem Res 24: 1169-1180.
5. Bluthe RM, Castanon N, Pousset F, Bristow A, Ball C, Lestage J et al (1999). Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 24: 301-311.
6. Bluthe RM, Dantzer R, Kelley KW (1997). Central mediation of the effects of interleukin-1 on social exploration and body weight in mice. Psychoneuroendocrinology 22: 1-11.
7. Borsini F, Meli A (1988). Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94: 147-160.
8. Bousquet C, Ray DW, Melmed S (1997). A common pro-opiomelanocortin- binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. Biol Chem 272: 10551-10557.
9. Butzkueven H, Zhang JG, Soilu-Hanninen M, Hochrein H, Chionh F, Shipham KA et al (2002). LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8: 613-619.
10. Cervini R, Berrard S, Bejanin S, Mallet J (1994). Regulation by CDF/LIF and retinoic acid of multiple ChAT mRNAs produced from distinct promoters. J Neurorep 5: 1346-1348.
11. Cheng J-C, Patterson PH (1997). LIF is an autocrine factor for sympathetic neurons. Mol Cell Neurosci 9: 372-380.
12. Chesnokova V, Auernhammer CJ, Melmed S (1998). Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 139: 2209-2216.
13. Chesnokova V, Kariagina A, Melmed S (2002). Opposing effects of leukemia inhibitory factor and suppressor of cytokine signaling 3 on the ACTH axis response to inflammation. Am J Physiol Endocrinol Metab 282: E1110-E1118.
14. Chesnokova V, Melmed S (2000). Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation. Endocrinology 141: 4032-4040.
15. Connor TJ, Leonard BE (1998). Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62: 583-606.
16. Cunningham Jr ET, De Souza EB (1993). Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today 14: 171-176.
17. Dantzer R, Wollman E, Vitkovic L, Yirmiya R (1999). Cytokines and depression: fortuitous or causative association? Mol Psychiatry 4: 328-332.
18. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K (2002). Depression: perspectives from affective neuroscience. Ann Rev Psychol 53: 545-574.
19. Dawson GR, Tricklebank MD (1995). Use of the elevated plus maze in the search of novel anixolytic agents. Trends Pharmacol Sci 16: 33-36.
20. Dunn AJ, Wang J, Ando T (1999). Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol 461: 117-127.
21. Gadient RA, Lein P, Higgins D, Patterson PH (1998). Effect of leukemia inhibitory factor (LIF) on the morphology and survival of cultured hippocampal neurons and glial cells. Brain Res 798: 140-146.
22. Gertsik L, Poland RE (2004). Psychoneuroendocrinology. In: Schatzberg A, Nemeroff CB (eds). Textbook of Psychopharmacology, 3rd edn. American Psychiatric Publishing: Arlington, VA. pp 115-129.
23. Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H (1999). Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J Neurosci 19: 5654-5665.
24. Heyes MP, Saito K, Chen CY, Proescholdt MG, Nowak Jr TS, Li J et al (1997). Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. J Neurochem 69: 1519-1529.
25. Kent S, Bluthe RM, Kelley KW, Dantzer R (1992). Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13: 205-208.
26. Konsman JP, Parnet P, Dantzer R (2002). Cytokine-induced sickness behavior: mechanisms and implications. Trends Neurosci 25: 154-159.
27. Lemke R, Gadient RA, Schliebs R, Bigl V, Patterson PH (1996). Neuronal expression of leukemia inhibitory factor (LIF) in the rat brain. Neurosci Lett 13: 205-208.
28. Leonard BE (2001). The immune system, depression and the action of antidepressants. Prog Neuro-Psychopharmacol Biol Psychiat 25: 767-780.
29. Licinio J, Wong ML (1997). Pathways and mechanisms for cytocine signaling in the central nervous system. J Clin Invest 100: 2941-2947.
30. Licinio J, Wong ML (1999). The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4: 317-327.
31. Maes M (1999). Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461: 25-46.
32. Manji HK, Drevets WC, Charney DS (2001). The cellular neurobiology of depression. Nat Med 7: 541-547.
33. Miller AH (1998). Neuroendocrine and immune system interactions in stress and depression. Psychoneuroendocrinology 21: 443-463.
34. Mossner R, Lesch KP (1998). Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 12: 249-271.
35. Nemeroff CB (1996). The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1: 336-342.
36. Porsolt RD, Bertin A, Jalfre M (1977a). Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327-336.
37. Porsolt RD, Le Pichon M, Jalfre M (1977b). Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730-732.
38. Ramamoorthy S, Ramamoorthy JD, Prasad PD, Bhat GK, Mahesh VB, Leibach FH et al (1995). Regulation of the human serotonin transporter by interleukin-1 beta. Biochem Biophys Res Commun 216: 560-567.
39. Reichlin S (1999). Neuroendocrinology of infection and the innate immune system. Recent Prog Harm Res 54: 133-181.
40. Rudge JS, Eaton MJ, Mather P, Lindsay RM, Whitte RS (1996). CNTF induces raphe neuronal precursors to switch from a serotonergic to a cholinergic phenotype in vitro. Mol Cell Neurosci 7: 204-221.
41. Shintani F, Nakaki T, Kanba S, Sato K, Yagi G, Shiozawa M et al (1995). Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J Neurosci 15: 1961-1970.
42. Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J (1998). The expressions of mRNAs for interleukin-6 (IL-6) and the IL-6 receptor (IL-6R) in the rat hypothalamus and midbrain during restraint stress. Life Sci 62: 2315-2320.
43. Stewart CL, Kaspar LJP, Brunet H, Bhatt I, Gadi I, Kontgen S et al (1992). Blastocytes implantation depends on maternal expression of leukemia inhibitory factor. Nature 359: 76-79.
44. Sugiura S, Lahav R, Han J, Kous S-Y, Banner L, de Pablo F et al (2000). Leukaemia inhibitory factor is required for normal inflammatory response to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci 12: 457-466.
45. Suzuki E, Shintani F, Kanba S, Asai M, Nakaki T (1996). Induction of interleukin-1b and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain. Neurosci Letters 13: 201-204.
46. Turnbull AV, Rivier CL (1999). Regulation of the hypothalamic-pituitary- adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev: 79: 1-71.
47. Vitkovic L, Bockert J, Jacque C (2000). 'Inflammatory' cytokines: neuromodulators in normal brain? J Neurochem 74: 457-471.
48. Yamada K, Iida R, Miyamoto Y, Saito K, Sekikawa K, Seishma M et al (2000). Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-α gene: implications for emotional behavior. J Neuroimmunol 111: 131-138.
49. Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R et al (2000). Illness, cytokines, and depression. Ann NY Acad Sci 917: 478-487.
50. Yirmiya R, Weidenfeld J, Pollak Y, Morgan M, Avitsur R, Barak O et al (1999). Cytokines, 'depression due to a general medical condition,' and antidepressant drugs. In: Dantzer et al (eds). Cytokines, Stress and Depression. Plenum: New York. pp 283-316.
51. Wichers M, Maes M (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 5: 375-388.